Ionis Pharmaceuticals, Inc. (IONS) earnings
IONS earnings moved a median of -0.07% by the close. Quarterly and annual IONS reports and results, each read against the price at its own news timestamp. Back to the IONS overview →
30 measured IONS earnings events.
Where these IONS earnings landedvs 30 measured IONS earnings reactions
| Middle 50% of IONS earnings reactions | -0.92% to +1.00% |
|---|---|
| Median reaction (to close) | -0.07% |
| Measured reactions | 30 |
Point-in-time · zero look-ahead
Half of the 30 IONS earnings events with a measured close landed between -0.92% and +1.00%; 47% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q IONIS PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | -0.41% | -1.19% | |
| Ionis reports second quarter 2026 financial results and highlights progress on key programs | Press release | -1.62% | -1.76% | |
| Ionis to hold second quarter 2026 financial results webcast | Press release | -0.79% | +0.46% | |
| Form 10-Q IONIS PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | +0.33% | +1.59% | |
| Ionis reports first quarter 2026 financial results and highlights progress on key programs | Press release | -0.25% | +3.84% | |
| Ionis to hold first quarter 2026 financial results webcast | Press release | -0.30% | -0.36% | |
| Form 10-K IONIS PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | +0.39% | +0.69% | |
| Form 10-Q IONIS PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | +0.68% | +3.50% | |
| Ionis reports third quarter 2025 financial results and highlights progress on key programs | Press release | -0.17% | -0.68% | |
| Ionis to hold third quarter 2025 financial results webcast | Press release | -0.31% | -0.07% | |
| Form 10-Q IONIS PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | +0.10% | +0.10% | |
| Ionis reports second quarter 2025 financial results and highlights progress on key programs | Press release | -0.63% | -0.99% | |
| Ionis to hold second quarter 2025 financial results webcast | Press release | +0.21% | +1.62% | |
| Form 10-Q IONIS PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | -0.41% | -0.41% | |
| Ionis reports first quarter 2025 financial results | Press release | -6.02% | -3.49% | |
| Ionis to hold first quarter 2025 financial results webcast | Press release | -0.25% | -0.07% | |
| Form 10-K IONIS PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | -1.47% | +3.12% | |
| Form 10-Q IONIS PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | -0.34% | -2.63% | |
| Ionis reports third quarter 2024 financial results | Press release | -2.05% | -2.28% | |
| Ionis to hold third quarter 2024 financial results webcast | Press release | -0.08% | -1.06% | |
| Form 10-Q IONIS PHARMACEUTICALS For: Jun 30 | SEC filing · Form 10-Q | -0.97% | -0.63% | |
| Ionis reports second quarter 2024 financial results | Press release | +0.28% | +2.89% | |
| Ionis to hold second quarter 2024 financial results webcast | Press release | -0.10% | +0.67% | |
| Form 10-Q IONIS PHARMACEUTICALS For: Mar 31 | SEC filing · Form 10-Q | +0.20% | +0.20% | |
| Ionis reports first quarter 2024 financial results | Press release | +1.93% | -0.07% | |
| Ionis to hold first quarter 2024 financial results webcast | Press release | -0.90% | +1.36% | |
| Form 10-K IONIS PHARMACEUTICALS For: Dec 31 | SEC filing · Form 10-K | +0.41% | +1.01% | |
| Form 10-Q IONIS PHARMACEUTICALS For: Sep 30 | SEC filing · Form 10-Q | +0.10% | -0.68% | |
| Ionis reports third quarter 2023 financial results | Press release | +0.02% | -5.02% | |
| Ionis to hold third quarter 2023 financial results webcast | Press release | -0.72% | +0.95% |
Keep exploring
More IONS: analyst actions → · SEC filings → · IONS overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Sinovac Biotech, Ltd. - Ordinary Shares (Antigua/Barbudo) (SVA) | 814 | 0.00% | 46% |
| Atara Biotherapeutics, Inc. (ATRA) | 813 | -0.27% | 45% |
| Applied Genetic Technologies Corporation (AGTC) | 805 | 0.00% | 45% |
| KERYX BIOPHARMACEUTICALS (KERX) | 804 | 0.00% | 51% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.